ARCHIVES

Impact Of DRGs On Clinical Research Less Than First Feared, Speakers Tell NIH Directors Meeting

This article is from The Cancer Letter archive.

Vol. 12 No. 25 | June 20, 1986

Download PDF Visit The Full Archive

Related Articles

Wyngaarden Recommendation On New Director Due Nov. 1o; Five Staff Members Nominated

November 4, 1988

Study Tracks Lifestyle Factors For Cancer Burden In Blacks

October 26, 2001

Tykerb Plus Herceptin Better Than Monotherapy, Study Says

December 25, 2009

In Brief: Megastrol Acetate Still Under FDA Review; Mays Hired For NCI’s Technology Office

July 20, 1990

DuBois Succeeds Hait As AACR President, Jacks Is President-Elect.

April 18, 2008

Clinical Trials Approved By NCI CTEP Last Month

February 25, 2011